Cargando…
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation
The p38 inhibitor SB202190 is a necessary component of the medium used for normal colorectal mucosa cultures. Sato et al. suggested that the primary activity of SB202190 may be EGFR signaling stabilization, causing an increased phosphorylation of Erk1-2 sustaining organoid proliferation. However, th...
Autores principales: | Costa, Delfina, Venè, Roberta, Coco, Simona, Longo, Luca, Tosetti, Francesca, Scabini, Stefano, Mastracci, Luca, Grillo, Federica, Poggi, Alessandro, Benelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954675/ https://www.ncbi.nlm.nih.gov/pubmed/36831331 http://dx.doi.org/10.3390/cells12040664 |
Ejemplares similares
-
Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
por: Costa, Delfina, et al.
Publicado: (2018) -
In Vitro Effects of SB202190 on Echinococcus granulosus
por: Lv, Hailong, et al.
Publicado: (2013) -
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy
por: Venè, Roberta, et al.
Publicado: (2020) -
A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190
por: Glover, Mark, et al.
Publicado: (2010) -
Human Gut-Associated Natural Killer Cells in Health and Disease
por: Poggi, Alessandro, et al.
Publicado: (2019)